Extracellular Vesicle/Macrophage Axis: Potential Targets for Inflammatory Disease Intervention

Front Immunol. 2022 Jun 13:13:705472. doi: 10.3389/fimmu.2022.705472. eCollection 2022.

Abstract

Extracellular vesicles (EVs) can regulate the polarization of macrophages in a variety of inflammatory diseases by mediating intercellular signal transduction and affecting the occurrence and development of diseases. After macrophages are regulated by EVs, they mainly show two phenotypes: the proinflammatory M1 type and the anti-inflammatory M2 type. A large number of studies have shown that in diseases such as mastitis, inflammatory bowel disease, Acute lung injury, and idiopathic pulmonary fibrosis, EVs promote the progression of the disease by inducing the M1-like polarization of macrophages. In diseases such as liver injury, asthma, and myocardial infarction, EVs can induce M2-like polarization of macrophages, inhibit the inflammatory response, and reduce the severity of the disease, thus indicating new pathways for treating inflammatory diseases. The EV/macrophage axis has become a potential target for inflammatory disease pathogenesis and comprehensive treatment. This article reviews the structure and function of the EV/macrophage axis and summarizes its biological functions in inflammatory diseases to provide insights for the diagnosis and treatment of inflammatory diseases.

Keywords: M1-like macrophage polarization; M2-like macrophage polarization; extracellular vesicle; inflammation; macrophages.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Lung Injury* / metabolism
  • Anti-Inflammatory Agents / metabolism
  • Extracellular Vesicles* / metabolism
  • Female
  • Humans
  • Macrophages / metabolism
  • Signal Transduction

Substances

  • Anti-Inflammatory Agents